Dr. Jianhai Guo 郭建海
Chief Physician
Department of Interventional Therapy, Peking University Cancer Hospital, Beijing
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Image-guided minimally invasive interventional oncology, including arterial pump infusion chemotherapy, chemoembolization, percutaneous tumor ablation (thermal and argon-helium cryoablation), radioactive seed implantation, vertebroplasty, and port implantation for various malignancies.
Dr. Guo holds a medical doctorate and serves as Chief Physician in the Department of Interventional Therapy at Peking University Cancer Hospital. Dr. Guo participated in five national, Beijing municipal, and investigator-initiated projects as a key researcher. Dr. Guo has published over 10 academic papers, including four SCI-indexed papers as first author.
Professional roles
- Member, Tumor Interventional Study Group, First Committee of the Interventional Medicine Branch, Chinese Medical Association
- Member, Expert Committee on Liver Metastasis and Conversion Therapy, Tumor Intervention Professional Committee, China Anti-Cancer Association
Name order: in Chinese the family name comes first (Guo Jianhai). Papers usually list the name as Jianhai Guo or Guo J.
Selected publications
30 papers on PubMed matched by name and affiliation; 5 as first or senior author since 2016. Most recent first- or senior-author papers:
- J Vasc Interv Radiol, 2021 (first author): γ-Glutamyltranspeptidase as a Prognostic Biomarker in Advanced Hepatocellular Carcinoma Treated with Transarterial Chemoembolization. PubMed 33067120
- AJR Am J Roentgenol, 2021 (first author): Percutaneous Microwave Ablation of Category T1a Renal Cell Carcinoma: Intermediate Results on Safety, Technical Feasibility, and Clinical Outcomes of 119 Tumors. PubMed 32603227
- J Endourol, 2020 (first author): Percutaneous Microwave Ablation of Stage T1b Renal Cell Carcinoma: Short-Term Assessment of Technical Feasibility, Short-Term Oncologic Outcomes, and Safety. PubMed 32498630
- World J Gastroenterol, 2020 (first author): Transarterial chemoembolization with hepatic arterial infusion chemotherapy plus S-1 for hepatocellular carcinoma. PubMed 32774071
- World J Gastroenterol, 2017 (first author): Hepatic artery infusion with raltitrexed or 5-fluorouracil for colorectal cancer liver metastasis. PubMed 28293087
- Chin J Cancer Res, 2014 (senior author): A comparative study between Embosphere(®) and conventional transcatheter arterial chemoembolization for treatment of unresectable liver metastasis from GIST. PubMed 24653635
- Anticancer Drugs, 2014 (senior author): Low-dose, short-interval target vessel regional chemotherapy through the hepatic artery combined with transarterial embolization in gastric cancer patients with liver metastases after failure of first-line or second-line chemotherapy: a preliminary analysis. PubMed 24185381
- Zhonghua Yi Xue Za Zhi, 2013 (senior author): [Angiographic findings and interventional therapy for post-pancreaticoduodenectomy hemorrhage]. PubMed 23578457
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion